galactosamine has been researched along with E coli Infections in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 8 (88.89) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bucklin, SE; Lake, P; Lögdberg, L; Morrison, DC | 1 |
| Bucklin, SE; Morrison, DC | 2 |
| Carpenter, A; Cohen, J; Evans, TJ; Martin, R; Moyes, D | 1 |
| Bucklin, SE; Fujihara, Y; Leeson, MC; Morrison, DC | 1 |
| Fleisher, GR; Kuppermann, N; Nelson, DS; Novitsky, TJ; Saladino, RA; Sattler, F; Siber, GR; Thompson, CM | 1 |
| Bailat, S; Baumgartner, JD; Di Padova, F; Glauser, MP; Heumann, D; Le Roy, D; Rietschel, ET | 1 |
| Guenounou, M; Lenaour, R; Mandine, E; Smets, P; Vacheron, F; Zalisz, R | 1 |
| Mäkelä, PH; Nurminen, M; Pyhälä, L; Vuopio-Varkila, J | 1 |
9 other study(ies) available for galactosamine and E coli Infections
| Article | Year |
|---|---|
Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia.
Topics: Animals; Bacteremia; Dextrans; Disease Models, Animal; Drug Carriers; Endotoxins; Escherichia coli Infections; Female; Galactosamine; Imipenem; Lipopolysaccharides; Mice; Polymyxin B; Toxemia | 1995 |
Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of gram-negative sepsis.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Ceftazidime; Cell Wall; Escherichia coli Infections; Female; Galactosamine; Gram-Negative Bacterial Infections; Imipenem; Lipopolysaccharides; Mice; Mice, Inbred C3H; Sepsis | 1995 |
Protective effects of a recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in an animal model of gram-negative sepsis.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteremia; Blood Bactericidal Activity; Blood Proteins; Colony Count, Microbial; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Galactosamine; Lipopolysaccharides; Male; Membrane Proteins; Mice; Recombinant Proteins; Sepsis; Tumor Necrosis Factor-alpha | 1995 |
Differential antibiotic-induced release of endotoxin from gram-negative bacteria.
Topics: Animals; Ceftazidime; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Galactosamine; Imipenem; Lipid A; Lipopolysaccharides; Mice; Microbial Sensitivity Tests | 1994 |
Comparison of a recombinant endotoxin-neutralizing protein with a human monoclonal antibody to endotoxin for the treatment of Escherichia coli sepsis in rats.
Topics: Animals; Antibodies, Monoclonal; Antimicrobial Cationic Peptides; Arthropod Proteins; Bacteremia; Endotoxins; Escherichia coli Infections; Galactosamine; Horseshoe Crabs; Immunoglobulin M; Invertebrate Hormones; Lipid A; Male; Organometallic Compounds; Rats; Rats, Wistar; Recombinant Proteins | 1994 |
Bacteremia versus endotoxemia in experimental mouse leukopenia--role of antibiotic chemotherapy.
Topics: Animals; Antibodies, Monoclonal; Bacteremia; Ceftazidime; Cephalosporins; Cyclophosphamide; Endotoxemia; Escherichia coli; Escherichia coli Infections; Female; Galactosamine; Imipenem; Immunity, Innate; Interferon-gamma; Leukopenia; Mice; O Antigens; Thienamycins | 1996 |
Similarities and disparities between core-specific and O-side-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in mice.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Bacteremia; Cross Reactions; Disease Models, Animal; Endotoxemia; Epitopes; Escherichia coli Infections; Female; Galactosamine; Lipopolysaccharides; Mice | 1997 |
Inhibition of production of tumor necrosis factor by monoclonal antibodies to lipopolysaccharides.
Topics: Animals; Antibodies, Monoclonal; Escherichia coli Infections; Female; Galactosamine; Lipopolysaccharides; Mice; Tumor Necrosis Factor-alpha | 1992 |
Lipopolysaccharide-induced non-specific resistance to systemic Escherichia coli infection in mice.
Topics: Animals; Escherichia coli; Escherichia coli Infections; Galactosamine; Immunity, Active; Lipopolysaccharides; Mice; Mice, Inbred Strains; Time Factors | 1988 |